Victory Capital Management Inc Kala Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$8.33 - $13.79 $61,300 - $101,480	-7,359 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$3.83 - $8.79 $12,715 - $29,182	3,320 Added 82.2%	7,359 $65,000
Q4 2019 Feb 04, 2020	BUY	$3.36 - $4.81 $1,270 - $1,818	378 Added 10.33%	4,039 $24,000
Q3 2019 Nov 12, 2019	BUY	$3.57 - $6.58 $13,069 - $24,089	3,661 New	3,661 $14,000
Q3 2018 Nov 01, 2018	SELL	$9.54 - $13.87 $440,366 - $640,239	-46,160 Closed	0 $0

Q2 2018 Aug 02, 2018	SELL	$13.3 - $17.49 $30,856 - $40,576	-2,320 Reduced 4.79%	46,160 $634,000
Q1 2018 May 04, 2018	SELL	$12.26 - $18.98 $6.38 Million - $9.87 Million	-520,155 Reduced 91.47%	48,480 $767,000
Q4 2017 Feb 01, 2018	BUY	$13.68 - $23.17 $343,504 - $581,798	25,110 Added 4.62%	568,635 $10.5 Million
Q3 2017 Oct 27, 2017	BUY	$19.86 - $26.53 $10.8 Million - $14.4 Million	543,525	543,525 $12.4 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.